Methods of providing neuroprotection

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/27 (2006.01) A61K 31/451 (2006.01) A61K 31/4706 (2006.01) A61K 31/498 (2006.01)

Patent

CA 2251579

Novel methods are disclosed for treating asymptomatic, acute and chronic neurological disease and attenuating further neuronal cell death in neurological diseases, employing a glycine site antagonist at the NMDA (N- methyl-D-aspartate) complex, e.g., 2-phenyl-1,3-propanediol dicarbamate (felbamate).

Nouvelles méthodes de traitement des maladies neurologiques aigües et chroniques asymptomatiques et d'enrayement de la mort des cellules neuronales dans les maladies neurologiques. Ces méthodes consistent à utiliser un antagoniste du site glycine au niveau du complexe NMDA (N-methyl-D-aspartate), par exemple un dicarbamate 2-phényl-1,3-propanodiol (felbamate).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of providing neuroprotection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of providing neuroprotection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of providing neuroprotection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1994458

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.